OrthoTreat


Develops therapies and platform technologies for bone regeneration. Focus areas include a mechanism-based approach to modulate bone biology and a dual-drug formulation with controlled release to accelerate fracture healing, support osseointegration and address osteoporosis. Operates an open knowledge hub and a members-only professional community for clinical and scientific engagement.

Industries

Life Science
Medical
Pharmaceutical
Biotechnology Research

Nr. of Employees

small (1-50)

OrthoTreat

Tel Aviv-Yafo, Tel Aviv District, Israel


Products

Dual-drug therapeutic formulation (platform)

A dual-active therapeutic formulation with engineered controlled release to accelerate and support bone healing across inflammatory, reparative and remodelling phases.


Services

Publishing and curating articles, videos, glossaries and reference materials on bone regeneration and related topics.

A membership platform for clinicians and researchers to collaborate, share data and conduct surveys.

Expertise Areas

  • Bone regeneration
  • Mechanism-based regulation of bone biology
  • Controlled drug delivery for orthopedics
  • Preclinical translational research (ex vivo and in vivo)
  • Show More (4)

Key Technologies

  • Dual-drug combination therapies
  • Controlled multi-drug release systems
  • Biomaterials for therapeutic delivery
  • Statin-based osteogenic modulation
  • Show More (4)

News & Updates

Article describing controlled dual-release approaches for bone regeneration.

A systematic review and meta-analysis on statin use in bone regeneration.

Review on modulating inflammation to improve bone repair outcomes.

Patent pending / IP protection for composition-of-matter and mechanism claims supporting the platform technology.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.